Research on the methylation of the SHOX2 gene indicates a significant elevation in the methylation levels among lung cancer patients, which can be detected through blood samples and thus serve as an early diagnostic marker for asymptomatic high‐risk populations. This evidence concerns the gene SHOX2 and lung cancer.